These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9543118)

  • 21. New syndrome: familial proportionate short stature, intrauterine growth retardation, and recurrent locking of the fingers.
    Eng CE; Strom CM
    Am J Med Genet; 1987 Jan; 26(1):217-20. PubMed ID: 3812565
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinants of short stature and the response to growth hormone therapy.
    Dunger DB
    Horm Res; 2009 Apr; 71 Suppl 2():2-4. PubMed ID: 19407490
    [No Abstract]   [Full Text] [Related]  

  • 23. [Idiopathic short stature: growth hormone, a therapeutic challenge?].
    Sultan C
    Arch Pediatr; 2005 Sep; 12(9):1317-9. PubMed ID: 15994069
    [No Abstract]   [Full Text] [Related]  

  • 24. Growth hormone for short stature.
    FDA Consum; 2003; 37(6):6. PubMed ID: 14983812
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD; Blizzard RM; Johanson AJ; Furlanetto RW; Evans WS; Rivier J; Vale WW; Thorner MO
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height outcome of growth hormone-deficient patients treated since less than five years of age.
    De Luca F; Maghnie M; Arrigo T; Lombardo F; Messina MF; Bernasconi S
    Acta Paediatr; 1996 Oct; 85(10):1167-71. PubMed ID: 8922077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone treatment of Russell-Silver syndrome.
    Stanhope R; Albanese A; Azcona C
    Horm Res; 1998; 49 Suppl 2():37-40. PubMed ID: 9730671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease].
    Sieniawska M; Pańczyk-Tomaszewska M; Ziółkowska H; Jedrzejowski A; Leszczyńska B; Dyras P; Kałuzyńska A; Makulska I; Pietrzyk JA; Rubik J; Siteń G; Stachowski J; Szprynger K; Zurowska A; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2001 Apr; 10(58):263-6. PubMed ID: 11434172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the role of growth-hormone therapy in short children who were small for gestational age?
    Donaldson M
    Lancet; 2001 Aug; 358(9279):347-8. PubMed ID: 11502309
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrauterine growth retardation and long-term effects on growth.
    Botero D; Lifshitz F
    Curr Opin Pediatr; 1999 Aug; 11(4):340-7. PubMed ID: 10439208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficult tracheal intubation in a child born small for gestational age and receiving growth hormone therapy for short stature.
    Kira S; Arai C
    Paediatr Anaesth; 2012 May; 22(5):498-9. PubMed ID: 22486911
    [No Abstract]   [Full Text] [Related]  

  • 36. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation.
    Kawashima Y; Kanzaki S; Yang F; Kinoshita T; Hanaki K; Nagaishi J; Ohtsuka Y; Hisatome I; Ninomoya H; Nanba E; Fukushima T; Takahashi S
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4679-87. PubMed ID: 15928254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and self-esteem in children treated for idiopathic short stature.
    Sandberg DE
    J Pediatr; 2003 Nov; 143(5):691. PubMed ID: 14649665
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth hormone therapy.
    Bhatia V
    Indian Pediatr; 1997 Aug; 34(8):675-9. PubMed ID: 9492395
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth hormone insensitivity associated with a STAT5b mutation.
    Kofoed EM; Hwa V; Little B; Woods KA; Buckway CK; Tsubaki J; Pratt KL; Bezrodnik L; Jasper H; Tepper A; Heinrich JJ; Rosenfeld RG
    N Engl J Med; 2003 Sep; 349(12):1139-47. PubMed ID: 13679528
    [No Abstract]   [Full Text] [Related]  

  • 40. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration.
    Binder G; Seidel AK; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Eggermann T; Ranke MB
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1402-7. PubMed ID: 18230663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.